Contract Manufacturer Quality Audit Checklist

A thorough quality audit of a contract manufacturer (CM) begins weeks before you set foot in the facility. Pre-audit preparation determines whether the on-site visit produces actionable insights or wastes your time. Start by requesting the following documents from the CM at least 14 days before the audit date: current ISO certifications (ISO 9001 for quality management, ISO 22000 for food safety, ISO 22716 for cosmetics GMP, or industry-specific certifications), organizational chart showing quality team structure, list of major clients with reference contacts, most recent third-party audit report (if available), quality control procedures manual, corrective and preventive action (CAPA) log from the past 12 months, and a sample Certificate of Analysis (CoA) for a product similar to yours.

Review these documents before the visit to identify areas requiring deeper investigation on-site. Red flags in pre-audit documentation include: certifications that expired more than 30 days ago, a quality team of fewer than 3 people for a facility with more than 50 production workers (indicating insufficient quality coverage), refusal to share the CAPA log (suggesting they either do not maintain one or have embarrassing findings), and reference clients that are all small, unknown brands (indicating major brands have declined to work with them).

Prepare a structured audit checklist organized into five evaluation categories: facility and environment (25 percent of total score), quality management system (25 percent), production capability (20 percent), compliance documentation (15 percent), and workforce and training (15 percent). Each category contains 8 to 12 specific evaluation items scored on a 1-to-5 scale, producing a total audit score out of 100. A CM must score 75 or above to qualify as a potential partner, and 85 or above to proceed without conditional requirements.

Notify the CM of the audit agenda but not the specific items you will inspect. Share a general agenda (facility walkthrough in the morning, documentation review in the afternoon, management discussion at the end of day) but do not reveal your specific checklist items. This prevents the CM from staging specific areas while neglecting others. Request that the quality manager and production manager be present for the full audit day.

Bring the right tools to the audit: a camera (photographs are essential evidence), a calibrated thermometer and hygrometer (to verify environmental controls independently), your printed checklist, copies of the pre-audit documents for cross-referencing, and business cards. Dress appropriately for a manufacturing environment -- closed-toe shoes, long pants, and a hairnet or cap if the facility produces food or supplements. First impressions set the tone: arriving prepared and professionally equipped signals that you take quality seriously.

Begin the on-site audit with a facility walkthrough, moving from the raw material receiving area through production zones to finished goods storage and shipping. Follow the product flow path -- this reveals the logical layout of the facility and highlights potential contamination points where raw materials, work-in-progress, or finished goods could cross paths inappropriately. A well-designed facility has a unidirectional flow: raw materials enter on one side, finished products exit on the other, with no backtracking.

Evaluate the facility environment against these criteria: temperature and humidity are controlled and monitored (for food and supplement manufacturing, production areas should maintain 18 to 25 degrees Celsius and below 60 percent relative humidity), lighting is adequate for visual inspection tasks (minimum 300 lux in production areas, 500 lux in inspection areas), air handling systems include appropriate filtration (HEPA filtration for pharmaceutical-grade products, basic HVAC filtration for general consumer goods), and pest control evidence is visible (bait stations, door sweeps, sealed utility penetrations). Take temperature and humidity readings with your own instruments and compare to the CM's posted environmental monitoring data.

Inspect production equipment condition and maintenance records. Key indicators of well-maintained equipment: calibration stickers with current dates on all measuring instruments (scales, thermometers, pH meters), a posted preventive maintenance schedule with documented completion, spare parts inventory for critical equipment (indicating preparedness for breakdowns), and clean, organized workstations without accumulation of debris or product residue. Request to see the maintenance log for one critical piece of equipment -- if the CM cannot produce it within 5 minutes, their documentation system is unreliable.

Sanitation assessment is critical for food, supplement, and cosmetics manufacturers. Evaluate: cleaning procedures are documented with specific chemical concentrations and contact times, cleaning validation records show microbial testing after cleaning (for food and supplement production), dedicated cleaning equipment for different production zones (no cross-contamination from dirty mops), handwashing stations are accessible, stocked with soap and paper towels, and have signage with proper handwashing instructions, and employee personal hygiene practices are observed (hair nets, gloves, no jewelry, clean uniforms).

Score the facility inspection category (25 points maximum): Environmental controls adequate (5 points), Equipment condition and maintenance (5 points), Sanitation program documented and followed (5 points), Layout prevents cross-contamination (5 points), Pest control program in place and monitored (5 points). A score below 15 in this category is a disqualifying finding regardless of performance in other categories -- a facility that cannot maintain basic environmental standards cannot produce export-quality products.

The Quality Management System (QMS) is the documented framework that governs how the CM prevents, detects, and corrects quality issues. Evaluate the QMS at three levels: documentation (do written procedures exist?), implementation (are they actually followed?), and effectiveness (do they produce consistent results?). Many CMs have impressive-looking quality manuals that exist only on shelves -- your audit must verify that the documented system operates in practice.

Evaluate incoming material inspection procedures. Request to observe an actual incoming material inspection or review the records from the most recent 5 incoming shipments. Key questions: does the CM test incoming raw materials against a written specification before accepting them? What percentage of incoming lots are tested (should be 100 percent for critical ingredients, statistical sampling for packaging materials)? Are rejected lots quarantined and disposition-documented? If the CM accepts raw materials without testing them, they have no control over the quality of your finished product.

In-process quality control (IPQC) procedures reveal how the CM monitors production quality during manufacturing. Effective IPQC includes: process parameter monitoring at defined intervals (e.g., mixing speed and time every 30 minutes), in-process sampling and testing (e.g., weight checks every 100 units, visual inspection every 15 minutes), documented IPQC records with actual measured values (not just "pass/fail" checkmarks), and defined action limits that trigger production stoppage when exceeded. Request to see 3 recent IPQC records -- they should show actual measured values with timestamps and operator signatures.

Finished goods inspection procedures determine whether the CM ships compliant products. Evaluate: finished product testing against a written specification (CoA testing), statistical sampling plan for finished goods inspection (referencing AQL -- Acceptable Quality Limit -- standard ISO 2859-1), retention samples stored for stability monitoring and complaint investigation, and a clear hold-and-release procedure requiring quality team sign-off before shipping. The AQL level should be appropriate for your product: critical defects at AQL 0 (zero tolerance), major defects at AQL 1.0, and minor defects at AQL 2.5.

Score the QMS category (25 points maximum): QMS documentation complete and current (5 points), Incoming material inspection effective (5 points), In-process quality controls documented and followed (5 points), Finished goods testing and release procedures adequate (5 points), CAPA system active with evidence of corrective actions implemented (5 points). A CM that scores below 15 in this category can produce acceptable products when everything goes right but lacks the systems to prevent or catch quality problems -- a high-risk partner for export products where recalls and customer complaints have severe financial consequences.

Production capability assessment verifies that the CM can produce your specific product at the required volume, quality, and consistency. Start by requesting a trial production run (pilot batch) of 500 to 2,000 units before committing to full-scale production. A pilot batch costing US$2,000 to US$5,000 is the most cost-effective quality assurance investment you can make -- it reveals formulation compatibility with the CM's equipment, identifies process parameters that need adjustment, and produces samples for regulatory testing and listing photography.

Evaluate production capacity against your projected volume needs. Key questions: what is the CM's maximum monthly output for your product type? What percentage of their current capacity is utilized (above 85 percent utilization means limited flexibility for your orders)? What is the standard production lead time from order confirmation to shipment readiness (2 to 4 weeks is typical for supplement manufacturing, 3 to 6 weeks for more complex products)? Can they scale production by 50 percent within 30 days if your Amazon sales exceed projections? A CM running at 90 percent capacity with a 6-week lead time will cause you stockout problems during demand spikes.

Assess the CM's formulation and R&D capability. For supplement and food products, a CM with an in-house R&D team (at minimum, a formulation chemist and a quality chemist) can help you adapt formulations for different markets -- adjusting ingredient levels to comply with Japanese regulations, reformulating to replace ingredients not permitted by TGA, or developing new flavors for the US market. A CM without R&D capability can only produce to your exact specification, offering no value-added support.

Evaluate raw material sourcing and supply chain resilience. Ask: how many suppliers does the CM use for each critical raw material? (Single-sourcing is a risk.) What is the CM's raw material inventory policy? (Maintaining 30 to 60 days of critical material stock is standard.) Has the CM experienced raw material supply disruptions in the past 24 months, and how were they managed? A CM dependent on a single supplier for a critical ingredient can halt your production if that supplier experiences a disruption.

Score the production capability category (20 points maximum): Adequate capacity for your volume requirements (4 points), Lead time meets your replenishment cycle needs (4 points), Formulation and R&D support available (4 points), Raw material sourcing diversified (4 points), Pilot batch process in place (4 points). A score below 12 indicates production risk. Address specific gaps through contractual requirements (e.g., requiring the CM to maintain minimum 45-day raw material stock for your product) or consider a different CM.

Compliance documentation assessment verifies that the CM can provide the paperwork required for export to your target markets. This is not a theoretical exercise -- US FDA, Australian TGA, and Japan MHLW can all request manufacturing records during inspections or import reviews. A CM that cannot produce proper documentation on demand puts your regulatory standing at risk.

For US-destined products, the CM must be able to provide: Certificate of Analysis (CoA) for every batch shipped (listing test methods, specifications, and actual results), batch manufacturing records showing the production process was followed as documented, raw material certificates from ingredient suppliers (traceability back to the ingredient source), stability data supporting the product's shelf life claim, and a current FDA facility registration number. For dietary supplements specifically, the CM must demonstrate compliance with 21 CFR 111 (cGMP for dietary supplements) through either FDA inspection history or third-party GMP certification from NSF International, UL, or similar bodies.

For Australia-destined products (TGA-listed therapeutic goods), the CM must provide: a TGA-compliant Certificate of GMP Compliance or PIC/S GMP certification (required for all manufacturers of TGA-listed medicines), batch-specific Certificates of Analysis tested by a NATA-accredited laboratory (or equivalent international accreditation), stability data following ICH guidelines (minimum 12-month accelerated stability and 24-month real-time stability for the claimed shelf life), and evidence of clean room classification appropriate for the product type.

For Japan-destined products, the CM must provide: ingredient specifications including purity levels and testing methods, heavy metal test results (Japan has particularly strict limits: arsenic below 2 ppm, lead below 10 ppm, mercury below 0.4 ppm for food products), microbiological test results meeting Japan's Food Sanitation Act standards, manufacturing process flow diagrams for submission to MHLW if required, and Japanese-language Certificates of Analysis (or English-language CoAs that your Japanese regulatory agent can translate and certify).

Final scoring methodology: sum the scores across all five categories for a total out of 100 points. Facility inspection (25 points) + QMS evaluation (25 points) + Production capability (20 points) + Compliance documentation (15 points) + Workforce and training (15 points) = total audit score. Interpret the result: 85 to 100 -- qualified, proceed with contract negotiation. 75 to 84 -- conditionally qualified, proceed with a corrective action plan for identified gaps (re-audit in 90 days). 60 to 74 -- significant gaps, do not proceed until the CM addresses deficiencies (re-audit in 6 months). Below 60 -- disqualified, do not engage. Share the audit results with the CM's management team and request a written response to any findings scored below 3/5 within 14 business days.